1. DOP048 Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease. (16th January 2018) Authors: Yarur, A; Bruss, A; Fox, C; Beniwal-Patel, P; Patel, A; Berens, B; Naik, S; Stein, D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P159 Patients with Inflammatory Bowel Disease Present with Lower Trabecular Bone Scores. (27th May 2021) Authors: Yarur, A; Alexandra, B; Beniwal-Patel, P; Stein, D; Nunez, L; Berens, B; Shaina, S; Parakkal, D; Shaker, J; Jenna, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P325 Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study. (27th May 2021) Authors: Parakkal, D; Johnson, A; Fenster, M; Ramos, G; Zulqarnain, M; Ullman, T; Huang, L; Gutierrez, A; Bruss, A; Ungaro, R; Cohen, B; Gaurav, S; Anish, P; Sasankan, P; Costable, N; Pekow, J; Wang, W; Rubin, D; Ciorba, M; Beniwal-Patel, P Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. (25th January 2019) Authors: Ungaro, R; Fenster, M; Dimopoulos, C; Patel, A; Deepak, P; Syal, G; Yarur, A; Hirten, R; Christophi, G; Khatiwada, A; Lin, B; Colombel, J-F; Ha, C; Weisshof, R; Beniwal-Patel, P; Cohen, B; Pekow, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study. (25th January 2019) Authors: Yarur, A; Bixuan, L; Deepak, P; Khatiwada, A; Christophi, G; Ciorba, M; Ungaro, R; Fenster, M; Dimopoulos, C; Syal, G; Hirten, R; Colombel, J-F; Ha, C; Weisshof, R; Pekow, J; Patel, A; Beniwal-Patel, P; Cohen, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P552 Higher Serum Ustekinumab Levels Correlate With Higher Rates Of Steroid-Free Deep Remission And Endoscopic Healing In Patients With Inflammatory Bowel Diseases. (21st January 2022) Authors: Yarur, A; Ungaro, R; Jain, A; Nunex, L; Spencer, E; Bruss, A; Berens, B; Beniwal-Patel, P; Dervieux, T; Dubinsky, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗